Transcode Therapeutics (RNAZ) Non Operating Interest Expenses (2020 - 2025)
Transcode Therapeutics (RNAZ) posted Non Operating Interest Expenses of $542.00 for Q4 2025, down 70.4% from $1,832 a year earlier and down 90.9% from the prior quarter.
Powered by 
Analysis
Transcode Therapeutics (RNAZ) Non Operating Interest Expenses (2020 - 2025) Analysis & Trends
For FY2025, Transcode Therapeutics' Non Operating Interest Expenses came in at $6,616, down 75.3% from FY2024.
- Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -55.9% (FY2020 to FY2025).
- In prior years, Transcode Therapeutics' Non Operating Interest Expenses was $26,813 in FY2024 (-52.0%), $55,899 in FY2023 (+74.8%), $31,986 in FY2022 (-66.4%) and $95,070 in FY2021 (-75.9%).
- Quarterly Non Operating Interest Expenses has run from a low of $114.00 in Q1 2025 to a high of $52,770 in Q1 2021 over five years.
- The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q2 2021, with growth of 17.7%; the weakest was Q3 2021, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Transcode Therapeutics | 1.70 Mn | 1.70 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 542.00 |
| Sep 30, 2025 | 5,960.00 |
| Mar 31, 2025 | 114.00 |
| Dec 31, 2024 | 1,832.00 |
| Sep 30, 2024 | 10,792.00 |
| Jun 30, 2024 | 4,482.00 |
| Mar 31, 2024 | 9,706.00 |
| Dec 31, 2023 | 17,345.00 |
| Sep 30, 2023 | 17,282.00 |
| Jun 30, 2023 | 7,843.00 |
| Mar 31, 2023 | 13,429.00 |
| Sep 30, 2021 | 333.00 |
| Jun 30, 2021 | 41,966.00 |
| Mar 31, 2021 | 52,770.00 |
| Dec 31, 2020 | 53,864.00 |
| Sep 30, 2020 | 280,277.00 |
| Jun 30, 2020 | 35,650.00 |
API Access
Transcode Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RNAZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RNAZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RNAZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();